Search

everythinglearnresearchcommunity

for

Search:↓

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Testosterone in our bodies helps increase insulin secretion from the pancreas.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Blocking TRPV3 may help treat itch in dry skin conditions.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

AQB reduces harmful skin changes in systemic sclerosis.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

The combination therapy was effective and well-tolerated, especially in young patients.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.